B-cell lymphoma
B-cell lymphoma, the most common subtype of Non-Hodgkin’s lymphoma affects B-cells of the immune system. About 85 percent of patients of Non-Hodgkin’s lymphoma diagnosed with B-cell lymphoma. B-cell lymphoma is a very destructive and rapidly growing cancer of B-cells. B-cell lymphoma may prove fatal if not treated on time.
B-cell lymphoma has many subtypes that include the following;
- Primary effusion lymphoma: The individuals having a weak immune system are more prone to developing primary effusion lymphoma.
- Hairy cell leukemia: this type of cancer occurs in the blood, lymph nodes, and spleen. This cancer is also not very rapidly growing.
- Nodal marginal zone B-cell lymphoma: This subtype of B-cell lymphoma is not rapidly growing and rarely develops in the lymph nodes.
- Extranodal marginal zone B-cell lymphoma: this type of cancer occurs most commonly in the eyes, salivary glands, thyroid, skin, and lungs. It can also occur in the stomach.
- Splenic marginal zone B-cell lymphoma: this type of B-cell lymphoma occurs in the bone marrow and spleen. Splenic marginal zone B-cell lymphoma is not rapidly growing and has a high recovery rate.
- Primary central nervous system lymphoma: The patients of Acquired Immunodeficiency Syndrome (AIDS) and the individuals who undergone organ transplantation have more risk of developing primary central nervous system lymphoma. This cancer most commonly occurs in the spinal cord and brain.
- Diffuse large B-cell lymphoma: Diffuse large B-cell lymphoma (DLBCL) develops in the lymph nodes and other body organs. This subtype is the most common type of B-cell lymphoma cancer. DLBCL is destructive, but may be treated by a proper treatment plan.